Form 8-K - Current report:
SEC Accession No. 0001736730-25-000072
Filing Date
2025-09-10
Accepted
2025-09-10 07:01:18
Documents
16
Period of Report
2025-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K camp-20250909.htm   iXBRL 8-K 51219
2 EX-4.1 exhibit41-formofprexfunded.htm EX-4.1 120431
3 EX-10.1 exhibit101-securitiespurch.htm EX-10.1 363397
4 EX-10.2 exhibit102-registrationrig.htm EX-10.2 141105
5 EX-99.1 exhibit991-pressrelease.htm EX-99.1 20901
  Complete submission text file 0001736730-25-000072.txt   953087

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250909.xsd EX-101.SCH 1770
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20250909_lab.xml EX-101.LAB 24358
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20250909_pre.xml EX-101.PRE 14111
18 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250909_htm.xml XML 3038
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42365 | Film No.: 251304650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)